A Phase I/II randomised study of Tarceva (Elotonib), used concurrently with thoracic radiation in patients with advanced non-small cell lung cancer.
Imperial College NHS Healthcare Trust
West Midlands - Edgbaston Research Ethics Committee
Date of REC Opinion
14 Oct 2008
Further Information Favourable Opinion